about
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of C...
Read More
2.14
0.04
(1.90%)
137.2K
XNAS Volume
XNAS 16 Jul, 2025 3:18 PM (EDT)
Board Meeting
The next board meeting for I-Mab - ADR is on 22 Jul 2025 for the purpose of I-MAB Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
I-Mab - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..